IP Verse

Krka Tovarna Zdravil, D.d., Novo Mesto opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Nov 22, 2023

Title:

Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts

Oppositions:

Patent:

Grant Date:

Apr 8, 2020

Title:

Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2588090	Nov 22, 2023	Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts	3
EP2585051	Apr 8, 2020	Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts	1

EDER, MICHAEL

GENERICS [UK] LTD

GEORG KALHAMMER/STEPHAN TEIPEL

Feel free to send us a message here and we will get back to you